CNBX Pharmaceuticals Inc (CNBX)

[EnergySaver]

CNBX Added To The U.S. Marijuana Index today: FORBES.COM

https://www.forbes.com/sites/debraborchardt/2017/04/12/here-are-the-5-stocks-added-to-the-u-s-marijuana-index

Cannabics Pharmaceuticals develops and licenses cannabinoid-based treatments and therapies. The company's research division is based in Israel, where it is licensed for its work in both scientific and clinical research. The company specializes in the development of personalized anti-cancer and palliative treatments. Most recently the company announced results that indicated its cannabinoid compounds caused cancer cell death with no effects on healthy cells. The results pave the way for a possible antitumor treatment. The company has a market capitalization of $236 million and the stock has risen over 2,000% for the past year.